These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 24260981)

  • 1. Predictive value of the response to inhaled adenosine 5'-monophosphate for reducing the dose of inhaled corticosteroids in asthma.
    Prieto L; Ferrer A; Domenech J; López V; Marin J
    J Investig Allergol Clin Immunol; 2013; 23(5):351-8. PubMed ID: 24260981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Airway responsiveness to adenosine 5'-monophosphate and exhaled nitric oxide measurements: predictive value as markers for reducing the dose of inhaled corticosteroids in asthmatic subjects.
    Prieto L; Bruno L; Gutiérrez V; Uixera S; Pérez-Francés C; Lanuza A; Ferrer A
    Chest; 2003 Oct; 124(4):1325-33. PubMed ID: 14555562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modifications in forced vital capacity during adenosine monophosphate-induced bronchoconstriction in asthma: relationship with the response to methacholine and the effect of inhaled corticosteroids.
    Prieto L; López V; Catalan P; Barato D; Marín J
    Ann Allergy Asthma Immunol; 2009 May; 102(5):393-9. PubMed ID: 19492660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative cutoff points for adenosine monophosphate and methacholine challenge testing.
    Fardon TC; Fardon EJ; Hodge MR; Lipworth BJ
    Ann Allergy Asthma Immunol; 2004 Oct; 93(4):365-72. PubMed ID: 15521373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Airway obstruction induced by inhaled acetaldehyde in asthma: repeatability relationship to adenosine 5'-monophosphate responsiveness.
    Prieto L; Gutiérrez V; Cervera A; Liñana J
    J Investig Allergol Clin Immunol; 2002; 12(2):91-8. PubMed ID: 12371536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doubling daily inhaled corticosteroid dose is ineffective in mild to moderately severe attacks of asthma in adults.
    Rice-McDonald G; Bowler S; Staines G; Mitchell C
    Intern Med J; 2005 Dec; 35(12):693-8. PubMed ID: 16313543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors for failed dose reduction of inhaled corticosteroids in childhood asthma.
    Li AM; Tsang TW; Lam HS; Sung RY; Chang AB
    Respirology; 2008 May; 13(3):400-7. PubMed ID: 18399863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does body mass index influence responsiveness to inhaled corticosteroids in persistent asthma?
    Anderson WJ; Lipworth BJ
    Ann Allergy Asthma Immunol; 2012 Apr; 108(4):237-42. PubMed ID: 22469442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-response comparison of budesonide dry powder inhalers using adenosine monophosphate bronchial challenge.
    Lipworth BJ; Sims EJ; Das SK; Buck H; Paterson M
    Ann Allergy Asthma Immunol; 2005 Jun; 94(6):675-81. PubMed ID: 15984601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhaled corticosteroids in children: use and effects of early treatment on asthma and lung function. Prevalence of asthma and the impact of severity in early life on later asthma in childhood.
    Devulapalli CS
    Clin Respir J; 2008 Oct; 2(4):247-8. PubMed ID: 20298343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Add-on salmeterol compared to double dose fluticasone in pediatric asthma: a double-blind, randomized trial (VIAPAED).
    Gappa M; Zachgo W; von Berg A; Kamin W; Stern-Sträter C; Steinkamp G;
    Pediatr Pulmonol; 2009 Nov; 44(11):1132-42. PubMed ID: 19824054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single and short-term dosing effects of levocetirizine on adenosine monophosphate bronchoprovocation in atopic asthma.
    Lee DK; Gray RD; Wilson AM; Robb FM; Soutar PC; Lipworth BJ
    Br J Clin Pharmacol; 2004 Jul; 58(1):34-9. PubMed ID: 15206990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Moderate dose inhaled corticosteroids plus salmeterol versus higher doses of inhaled corticosteroids in symptomatic asthma.
    Masoli M; Weatherall M; Holt S; Beasley R
    Thorax; 2005 Sep; 60(9):730-4. PubMed ID: 16135679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ventilation heterogeneity predicts asthma control in adults following inhaled corticosteroid dose titration.
    Farah CS; King GG; Brown NJ; Peters MJ; Berend N; Salome CM
    J Allergy Clin Immunol; 2012 Jul; 130(1):61-8. PubMed ID: 22460065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Markers for step-down of inhaled corticosteroid therapy in adult asthmatics.
    Tsurikisawa N; Oshikata C; Tsuburai T; Mitsui C; Tanimoto H; Takahashi K; Sekiya K; Nakazawa T; Minoguchi K; Otomo M; Maeda Y; Saito H; Akiyama K
    Allergol Int; 2012 Sep; 61(3):419-29. PubMed ID: 22722811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler.
    Murphy K; Noonan M; Silkoff PE; Uryniak T
    Clin Ther; 2007 Jun; 29(6):1013-26. PubMed ID: 17692718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive markers of asthma exacerbation during stepwise dose reduction of inhaled corticosteroids.
    Leuppi JD; Salome CM; Jenkins CR; Anderson SD; Xuan W; Marks GB; Koskela H; Brannan JD; Freed R; Andersson M; Chan HK; Woolcock AJ
    Am J Respir Crit Care Med; 2001 Feb; 163(2):406-12. PubMed ID: 11179114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenetic study of the effects of NK2R G231E G>A and TBX21 H33Q C>G polymorphisms on asthma control with inhaled corticosteroid treatment.
    Ye YM; Lee HY; Kim SH; Jee YK; Lee SK; Lee SH; Park HS
    J Clin Pharm Ther; 2009 Dec; 34(6):693-701. PubMed ID: 20175803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Duration of the effect of inhaled corticosteroids on lung function and sensitivity of the respiratory tract in patients with bronchial asthma].
    Magnussen H; Willenbrock U; Jörres R
    Med Klin (Munich); 1995 Apr; 90(4):214-9. PubMed ID: 7776933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative potencies and time course of changes in adenosine 5'-monophosphate airway responsiveness with inhaled furosemide and bumetanide in asthma.
    Polosa R; Rajakulasingam K; Prosperini G; Church MK; Holgate ST
    J Allergy Clin Immunol; 1993 Aug; 92(2):288-97. PubMed ID: 8349939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.